Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1994-03-23
1996-11-05
Jones, W. Gary
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
435 4, 436 63, 436811, 424 91, 935 76, 935 77, 935 78, C12Q 168, G01N 3348
Patent
active
055716717
ABSTRACT:
Disclosed is a method for detecting Alzheimer's disease. The method comprises testing an individual for the presence of a mosaic population of cells in which some cells have two copies of chromosome 21 and some cells have three copies of chromosome 21. The presence of the mosaic population of cells is indicative of Alzheimer's disease in the individual.
REFERENCES:
Podlisny et al Science (1987) 238:669-671.
Potter, H., "Review and Hypothesis: Alzheimer Disease and Down Syndrome-Chromosome 21 Nondisjunction May Underlie Both Disorders," Am. J. Hum. Genet., 48:1192-1200 (1991).
Inzelberg, R., et al., "Effects of Atropine on Learning and Memory Functions in Dementia," Clinical Neuropharmacology, 13(3) :241-247 (1990).
Schweber, M. S., "Alzheimer's Disease and Down Syndrome," Progress in Clinical and Biol. Research, 317:247-267 (Alan R. Liss, Inc., 1989).
Lichter, P., et al., "Rapid Detection of Human Chromosome 21 Aberrations by in situ Hybridization," Proc. Natl. Acad. Sci. USA, 85:9664-9668 (1988).
Talamo, B. R., et al., "Pathological Changes in Olfactory Neurons in Patients with Alzheimer's Disease," Nature, 337:736-739 (1989).
Schweber, M., "A Possible Unitary Genetic Hypothesis for Alzheimer's Disease and Down Syndrome," Anals of NY Acad. Sciences, 450:223-238 (1985).
Madan, K., et al., "Premature Centromere Division (PCD): A Dominantly Inherited Cytogenetic Anomaly," Hum. Genet., 77:193-196 (1987).
Jabs, E. W., et al., "Centromere Separation and Aneuploidy in Human Mitotic Mutants: Roberts Syndrome," Mechanisms of Chrom. Dist. and Aneuploidy, 111-118 (Alan R. Liss, Inc., 1989).
Uchida, I. A., et al., "Chromosome Aberrations Induced in vitro by Low Doses of Radiation: Nondisjunction in Lymphocytes of Young Adults," Am. J. Hum. Genet., 27:419-429 (1975).
Romke, C., et al., "Roberts Syndrome and SC Phocomelia. A Single Genetic Entity," Clinical Genetics, 31:170-177 (1987).
Moorhead, P. S., and Heyman, A., "Chromosome Studies of Patients with Alzheimer Disease," Amer. J. Of Med. Genet., 14:545-556 (1983).
Evans, D. A., et al., "Prevalence of Alzheimer's Disease in a Community Population of Older Persons," JAMA, 262(18):2551-2556 (1989).
Jarvik, L. F., et al., "Chromosomes and Mental Status," Arch. Gen. Psychiatry., 30:186-190 (1974).
Matsuyama, S. S., and Jarvik, L. F., "Hypothesis: Microtubules, a Key to Alzheimer Disease," Proc. Natl. Acad. Sci. USA, 86:8152-8156 (1989).
Nordenson, I., et al., "Chromosomal Abnormality in Dementia of Alzheimer Type," The Lancet, 481-482 (March 1, 1989).
Buckton, K. E., et al., "Chromosome Changes in Alzheimer's Presenile Dementia," J. of Med. Genet., 20:46-51 (1983).
Ward, B. E., et al., "Increased Aneuploidy in Alzheimer Disease," Amer. J. Of Med. Genet., 3:137-144 (1979).
White, B. J., et al., "Cytogenetic Studies of Familial and Sporadic Alzheimer Disease," Amer. J. of Med. Genet., 10:77-89 (1981).
Heston, L. L., and Mastri, A. R., "The Genetics of Alzheimer's Disease," Arch. Gen. Psychiatry, 34:976-981 (1977).
Heston, L. L., et al., "Dementia of the Alzheimer Type," Arch. Gen. Psychiatry, 38:1085-1090 (1981).
Lai, F., and Williams, R. S., "A Prospective Study of Alzheimer Disease in Down Syndrome," Arch. Neurol., 46:849-853 (1989).
Pagon, R. A., et al., "Abnormal Skin Fibroblast Cytogenetics in Four Dysmorphic Patients with Normal Lymphocyte Chromosomes," Am. J. Hum. Genet., 31:54-61 (1979).
Goate, A. M., et al., "Predisposing Locus for Alzheimer's Disease on Chromosome 21," The Lancet, 352-355 (Feb. 18, 1989).
Peters, G. B., et al., "Trisomy 21 Mosaicism and Maternal Age Effect," The Lancet, 1202-1203 (May 23, 1987).
Robison, S. H., et al., "Alzheimer's Disease Cells Exhibit Defective Repair of Alkylating Agent-Induced DNA Damage," Anals of Neurology, 21(3):250-258 (1987).
Hardy, J., et al., "Presenile Dementia Associated with Mosaic Trisomy 21 in a Patient with a Down Syndrome Child," The Lancet, 743 (Sep. 23, 1989).
Rowe, I. F., et al., "Presenile Dementia Associated with Mosaic Trisomy 21 in a Patient with a Down Syndrome Child," The Lancet, 229 (Jul. 22, 1989).
Harris, W. S. and Goodman, R. M., "Hyper-Reactivity to Atropine in Down's Syndrome," N.E. J. of Med., 279(8):407-410 (1968).
Fitzgerald, P. H., et al., "Evidence for the Repeated Primary Non-Disjunction of Chromosome 21 as a Result of Premature Centromere Division (PCD)," Hum. Genet., 72:58-62 (1986).
Sacks, B. and Smith S., "People with Down's Syndrome can be Distinguished on the Basis of Cholinergic Dysfunction," J. of Neurology, Neurosurgery, and Psych., 52:1294-1295 (1989).
Berg, J. W., et al., "Atropine in Mogolism," Lancet, 2:441-442 (1959).
Geller, L. N., et al., "Genetic and Clinical Links between Trisomy 21, Down Syndrome and Alzheimer's Disease," Society for Neuroscience Abstracts, Abstract #515.8, p. 1255 (1993).
Geller, L. N., et al., "Genetic and Clinical Links Between Trisomy 21, Down Syndrome, and Alzheimers's Disease," The American Society for Cell Biology, 4:246A Abstract #1426 (Dec. 1993).
Geller, L. N., et al., "Genetic and Clinical Links between Trisomy 21, Down Syndrome and Alzheimer's Disease," Amer. J. of Human Genet., 53, Sep. 1993 (Supplement), Abstract #548.
Jones W. Gary
Myers Carla
President and Fellows of Harvard College
LandOfFree
Method for detecting alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for detecting alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for detecting alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2014210